Eli Lilly and RNAi therapeutics specialist OliX Pharmaceuticals have entered into a global licensing agreement to advance a ...
To develop OliX’s OLX75016 candidate primarily targeting metabolic-associated steatohepatitis (MASH).
CarTrade Tech’s shares have surged 90% since October 2024, with a 305% increase from March 2023. The company reported strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback